首页> 外文OA文献 >Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group

【2h】

Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group

机译：澳大利亚和新西兰儿童癌症研究小组对新诊断为急性髓性白血病的儿童进行连续试验的结果

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
OBrien T.; Russell S.; Vowels M.; Oswald C.; Tiedemann K.; Shaw P.; Lockwood L.; Teague L.; Rice M.; Marshall G.;
展开▼
作者单位

展开▼
年度 2002
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group. [J] . Dusenbery KE, Howells WB, Arthur DC, Journal of pediatric hematology/oncology: Official journal of the American Society of Pediatric Hematology/Oncology . 2003,第10期

机译：新诊断为急性髓性白血病的儿童的髓外白血病：儿童癌症小组的报告。
2. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group. [J] . Tomizawa D, Tabuchi K, Kinoshita A, Pediatric blood & cancer . 2007,第2期

机译：高剂量阿糖胞苷的重复周期可有效治疗儿童急性髓性白血病：东京儿童癌症研究小组的两项连续试验表明，AML儿童的长期预后。
3. Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891 [J] . F O Smith, T A Alonzo, R B Gerbing, Leukemia . 2005,第12期

机译：儿童急性髓细胞性白血病的长期结果：儿童癌症小组的三项连续三期试验报告：CCG 251，CCG 213和CCG 2891
4. Clinical Trials for Childhood Acute Myeloid Leukemia at St. Jude Children's Research Hospital, 1980 through 2005 [C] . . 2006

机译：1980年至2005年在圣裘德儿童研究医院进行的儿童急性髓性白血病临床试验
5. Loss of Egr1 plays a role in murine leukemogenesis and may play a role in the development of acute myeloid leukemia and therapy-related acute myeloid leukemia. [D] . Joslin, John M. 2006

机译：Egr1的丢失在小鼠白血病的发生中起作用，并且可能在急性髓细胞性白血病和与治疗有关的急性髓细胞性白血病的发展中起作用。
6. Clinical Trials and Observations: P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808 [O] . Jonathan E. Kolitz, Stephen L. George, Guido Marcucci, -1

机译：临床试验和观察：对于新诊断为急性髓性白血病的60岁以下患者使用valspodar（PSC-833）抑制P-糖蛋白不能改善预后：癌症和白血病B组研究19808
7. Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213 [O] . RJ Wells, DC Arthur, A Srivastava, 2002

机译：新诊断的儿童和青少年的预后变量急性髓性白血病：儿童癌群研究213

Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group

著录项

引文网络

相似文献

相关主题

期刊订阅